Testing a new drug for advanced solid tumors
Part of Cancer clinical trials.
This trial is testing a new drug called HY07121 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 80 years old.
- Your cancer must have spread or come back after standard treatment, or no standard treatment is available.
- You need to have at least one measurable tumor that can be seen on a scan.
- You must be able to take care of yourself (ECOG score 0 or 1).
- If you could become pregnant, you need a negative pregnancy test and agree to use birth control during the study and for 6 months after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug given as an injection under the skin for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it can shrink tumors or slow their growth.
This trial studies a new drug called HW071021 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug can help shrink or control the cancer.
This trial tests a new drug, HY0001a, for people with advanced solid tumors that have not responded to standard treatments. The drug targets a protein on some cancer cells, and the study aims to find the right dose and see if it helps shrink tumors.
This trial tests an experimental drug called Hemay5087 for people with advanced solid tumors. It aims to find out if the drug is safe and how well it works, offering a possible option when standard treatments have failed.
This early-phase study (Phase 1) tests Hemay181, a new cancer medicine, in people with advanced solid tumors that have not been controlled by standard treatment. The goal is to see how the medicine works in the body and whether it can shrink or control tumors safely.
This trial tests a new drug, SYHA1813, given alone or with other treatments, for people with advanced solid tumors that cannot be removed by surgery or have spread. The goal is to see if it is safe and effective.
Hear when a new Safety trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.